Januvia’s Price Drop Exposes the PBM Profit Game

Januvia’s Price Drop Exposes the PBM Profit Game
Tuesday, March 18th, 2025

In a twist that defies logic for many patients, Merck, the pharmaceutical giant behind the blockbuster diabetes drug Januvia (sitagliptin), slashed its price dramatically in early 2025.

Read article

Healthcare Costs Unraveled: A Literacy Blueprint for Savings

Healthcare Costs Unraveled: A Literacy Blueprint for Savings
Monday, March 17th, 2025

In an increasingly complex and expensive healthcare landscape, the ability to navigate medical costs has become a critical skill for individuals and families.

Read article

Managing Kidney Stone Risks

Managing Kidney Stone Risks
Tuesday, March 4th, 2025

Kidney stones are a common but potentially serious health condition that affects millions of people worldwide. These hard mineral and salt deposits form inside the kidneys and can cause severe

Read article

Is There an Overpayment Problem in Medicare Part D

Is There an Overpayment Problem in Medicare Part D
Monday, March 3rd, 2025

Generic drugs make up 90% of all prescriptions filled in the US, offering a more affordable alternative to brand-name medications. However, research suggests that pharmacy benefit managers (PBMs) often reimburse

Read article

Mounjaro Might Benefit Your Heart Health

Mounjaro Might Benefit Your Heart Health
Thursday, February 20th, 2025

Mounjaro (tirzepatide) is primarily known for its role in managing Type 2 diabetes and supporting weight loss. However, growing evidence shows that this medication may also have significant benefits for

Read article

Tariff Speculation Puts Canada-U.S. Pharma Trade Under Scrutiny

Tariff Speculation Puts Canada-U.S. Pharma Trade Under Scrutiny
Thursday, February 20th, 2025

The Canadian pharmaceutical sector is facing uncertainty as the U.S. government is still publicizing they will move forward with a 25% tariff on imported goods, including medications.

Read article

Hope for Neurological Disorders

Hope for Neurological Disorders
Wednesday, February 12th, 2025

How Neural Interfaces Are Transforming Neurological Care: A New Era of Possibilities The Growing Challenge of Neurological Conditions Chronic neurological conditions such as paralysis, Alzheimer’s, and Parkinson’s disease affect millions

Read article

The Importance of Daily Exercise

The Importance of Daily Exercise
Wednesday, February 12th, 2025

Engaging in daily exercise is crucial for maintaining and enhancing overall health. Regular physical activity has been shown to improve cardiovascular health, strengthen muscles and bones, and boost energy levels.

Read article

Drug Price Reforms Ahead?

Drug Price Reforms Ahead?
Monday, January 27th, 2025

The high cost of prescription drugs remains a pressing concern for Americans, with many finding prices unreasonable. A survey by KFF revealed that while 65% of adults find it relatively

Read article

The Next Generation of Smart Pills

The Next Generation of Smart Pills
Monday, January 27th, 2025

On a crisp November morning in 2022, James Messenger took a step into the future by swallowing a pill unlike any he had encountered before. Having struggled with opioid addiction

Read article

Can a Blood Test Diagnose Alzheimer’s?

Can a Blood Test Diagnose Alzheimer’s?
Thursday, January 9th, 2025

The development of a blood test for Alzheimer’s represents a significant breakthrough in the fight against this debilitating disease. While it’s not yet available for everyday use, its potential to

Read article

Benefits of the MIND Diet

Benefits of the MIND Diet
Thursday, January 9th, 2025

In a world brimming with diet trends, finding a regimen that offers both simplicity and substantial health benefits can be challenging. Enter the MIND diet, a scientifically-backed approach designed to

Read article

Innovative Dementia Screening Tool Shows Promise

Innovative Dementia Screening Tool Shows Promise
Friday, January 3rd, 2025

A novel, cost-effective dementia screening test, known as qBEANS (Quick Behavioral Exam to Advance Neuropsychological Screening), has demonstrated potential in

Read article

Eli Lilly Launches Mounjaro KwikPen in Canada

Eli Lilly Launches Mounjaro KwikPen in Canada
Friday, January 3rd, 2025

Eli Lilly and Company has announced the Canadian release of the Mounjaro® (tirzepatide) KwikPen, a novel injectable medication designed to assist adults with type 2 diabetes in managing blood sugar

Read article

7 Effective Strategies to Prevent a Cold

7 Effective Strategies to Prevent a Cold
Friday, December 13th, 2024

While catching a cold may seem inevitable for most, the sneezing, runny nose, and sore throat that accompany it can last up to two weeks, making it an unpleasant experience.

Read article